Corbion falls after Berenberg cuts stock to 'hold'
** Shares in Corbion CORB.AS fall 7% after Berenberg cut the Dutch biochemical group to "hold" from "buy", saying all three factors it saw for a potential upside have now materialised
** The broker notes the share price is up around 25% since it moved to "buy" in August 2023, when it was bullish on growth in Omega-3 rich algae-derived oils business, debt reduction through divestments, and recovery in core ingredients volumes
** Berenberg "does not rule out" that Corbion could exit poly lactic acid (PLA) activities - bioplastic products with reduced carbon footprint - in 2025
** It says persisting headwinds weigh on PLA profitability, including European regulatory "antipathy" towards bioplastics, lower prices for conventional styrene and increases in Chinese PLA supply helped by sugar prices
** It raises PT to 26 euros from 24 euros, noting continuing strong performance in algea in Q3
** The shares are on track for their worst day since January if the losses hold
Reporting by Olivier Cherfan
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
